You are here

  • Home
  • Archive
  • Volume 9, Issue 1
  • CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer

Article metrics

Article menu
Immunotherapy biomarkers
Original research
CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer

 

Online download statistics by month:

Online download statistics by month: January 2021 to March 2026

AbstractFullPdf
Jan 2021541542292
Feb 2021332333127
Mar 2021186186105
Apr 202112312350
May 202115715762
Jun 202120820875
Jul 202119219277
Aug 202119919976
Sep 202118118185
Oct 2021209209118
Nov 2021157157115
Dec 202116116385
Jan 202216817978
Feb 202213413852
Mar 202213214271
Apr 202220122198
May 2022379392108
Jun 202221624497
Jul 202213413770
Aug 202214815676
Sep 2022185191116
Oct 202217918481
Nov 2022199206112
Dec 202215015059
Jan 202317217284
Feb 202319920691
Mar 2023397404134
Apr 202320220569
May 202316616676
Jun 202317918177
Jul 202319920284
Aug 2023199203104
Sep 202321221692
Oct 202323924263
Nov 202323523990
Dec 2023226228103
Jan 2024129132128
Feb 202419019075
Mar 2024318321209
Apr 2024277283130
May 2024261264119
Jun 2024231232102
Jul 2024251255106
Aug 202419619784
Sep 2024179186455
Oct 2024192193107
Nov 2024223232100
Dec 2024228234100
Jan 202518118487
Feb 2025219220127
Mar 2025215216101
Apr 2025241242142
May 2025260263124
Jun 202513714058
Jul 2025110
Mar 2026110
Total11426116405706